SMid Cap Biotech Analyst Joseph holds a conference call with CEO Evans will be held on October 31 at 11 am hosted by JPMorgan. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BEAM:
- Verve Therapeutics, Eli Lilly expand relationship
- Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
- Beam Therapeutics participates in a conference call with JPMorgan
- Beam Therapeutics reports new preclinical data from BEAM-301 studies
- Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCT